TP53 and cancer: With the analysis of 3,017 patient samples from 10 different TCGA cancer types (Fig. 1), we investigated whether the expression of our meta-analysis derived lncRNAs is reduced in samples with p53 loss-of-function (p53LOF) and whether it is consistently observed across multiple cancer types.